Search Results
Adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for HER2-positive breast cancer
5-year correlative analysis of ATEMPT: adjuvant T-DM1 vs paclitaxel+trastuzumab for stage I HER2+ BC
Dr. Sara Tolaney on Adjuvant T-DM1 Vs Paclitaxel and Trastuzumab for Stage I HER2+ Breast Cancer
Adjuvant treatment for stage I HER2+ breast cancer
T-DM1 Vs. Trastuzumab as Adjuvant Therapy for HER2-Positive Breast Cancer
ADAPT: de-escalated neoadjuvant pertuzumab+trastuzumab with or without paclitaxel in HR-/HER2+ eBC
Optimizing Therapy in HER2+ Disease with Dr. Reshma Mahtani
Dr. Tripathy on Trastuzumab Deruxtecan Versus T-DM1 in HER2-Expressing Breast Cancers
Which Chemotherapy With Adjuvant Trastuzumab and Pertuzumab?
Substituting trastuzumab emtansine for adjuvant trastuzumab improved IDFS for breast cancer pati...
New Data Comparing Adjuvant T-DM1 vs Trastuzumab for HER2+ Breast Cancer
Paclitaxel With Pertuzumab Plus Trastuzumab in Metastatic Breast Cancer
